214 related articles for article (PubMed ID: 37520202)
1. Application of honeybee venom loaded nanoparticles for the treatment of chronic toxoplasmosis: parasitological, histopathological, and immunohistochemical studies.
El Naggar HM; Anwar MM; Khayyal AE; Abdelhameed RM; Barakat AM; Sadek SAS; Elashkar AM
J Parasit Dis; 2023 Sep; 47(3):591-607. PubMed ID: 37520202
[No Abstract] [Full Text] [Related]
2. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
Mohammad OS; El Naggar HM; Abdelmaksoud HF; Barakat AM; Abdelhameed RM; Shehata MAS
Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
[TBL] [Abstract][Full Text] [Related]
3. Potential Anti-Toxoplasmosis Efficiency of
Wakid MH; Alsulami MN; Farid M; El Kholy WA
Infect Drug Resist; 2023; 16():7743-7758. PubMed ID: 38144223
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of silver nanoparticles and human platelet rich-plasma versus traditional therapy in the treatment of murine chronic toxoplasmosis.
Ibrahim SM; Al-Ghandour AMF; Mohamed SMA; Foaad HHM; El-Bahaie ES
J Parasit Dis; 2024 Jun; 48(2):217-228. PubMed ID: 38840885
[TBL] [Abstract][Full Text] [Related]
5. Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis.
Omar M; Abaza BE; Mousa E; Ibrahim SM; Rashed HE; Farag TI
J Parasit Dis; 2021 Dec; 45(4):1014-1025. PubMed ID: 34789985
[TBL] [Abstract][Full Text] [Related]
6. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
Zoghroban HS; Elmansory BM; Issa YA; Eltokhy AK; Abo Safia HS; El Maghraby GM; Salama AM
Exp Parasitol; 2023 May; 248():108515. PubMed ID: 36958594
[TBL] [Abstract][Full Text] [Related]
7. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
Allam AF; Hagras NA; Farag HF; Osman MM; Shalaby TI; Kazem AH; Shehab AY; Mogahed NMFH
J Parasit Dis; 2022 Mar; 46(1):166-177. PubMed ID: 35299902
[TBL] [Abstract][Full Text] [Related]
8. The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.
Hagras NA; Mogahed NMFH; Sheta E; Darwish AA; El-Hawary MA; Hamed MT; Elwakil BH
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010268. PubMed ID: 35294434
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
[TBL] [Abstract][Full Text] [Related]
11. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.
Etewa SE; El-Maaty DAA; Hamza RS; Metwaly AS; Sarhan MH; Abdel-Rahman SA; Fathy GM; El-Shafey MA
J Parasit Dis; 2018 Mar; 42(1):102-113. PubMed ID: 29491568
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis
Nishi L; Santana PL; Evangelista FF; Beletini LF; Souza AH; Mantelo FM; Souza-Kaneshima AM; Costa IN; Falavigna-Guilherme AL
Parasitology; 2020 Mar; 147(3):303-309. PubMed ID: 31727196
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
Abdelhamid Elgendy WM; Haggag YA; El-Nouby KA; El-Kowrany SI; El Marhoumy SM
Exp Parasitol; 2023 Mar; 246():108460. PubMed ID: 36642299
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen Increased Parasite Burden and Induced a Series of Histopathological and Immunohistochemical Changes During Chronic Toxoplasmosis in Experimentally Infected Mice.
Barakat AM; El Fadaly HAM; Selem RF; Madboli AEA; Abd El-Razik KA; Hassan EA; Alghamdi AH; Elmahallawy EK
Front Microbiol; 2022; 13():902855. PubMed ID: 35707167
[TBL] [Abstract][Full Text] [Related]
15. Nitazoxanide, Ivermectin, and Artemether effects against cryptosporidiosis in diabetic mice: parasitological, histopathological, and chemical studies.
El-Ashkar AM; Mahmoud S; Sabry H; Guirguis N; El Komi W; Ali E; Abu Shousha T; Abdelmksoud HF
J Parasit Dis; 2022 Dec; 46(4):1070-1079. PubMed ID: 36092469
[TBL] [Abstract][Full Text] [Related]
16. Changes and effect of PACAP-38 on intestinal ischemia-reperfusion and autotransplantation.
Ferencz A; Rácz B; Tamás A; Nedvig K; Németh J; Kalmár-Nagy K; Horváth OP; Wéber G; Röth E; Reglödi D
Transplant Proc; 2009; 41(1):57-9. PubMed ID: 19249475
[TBL] [Abstract][Full Text] [Related]
17. Histopathological and ultrastructural assessment of atovaquone-proguanil hydrochloride combination in chronic murine toxoplasmosis.
Elmehankar MS; Elhenawy AA; Aboukamar WA; Elzoheiry MA; Nabih N
Ultrastruct Pathol; 2021 Nov; 45(6):376-383. PubMed ID: 34595988
[TBL] [Abstract][Full Text] [Related]
18. Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model.
Gaafar MR; El-Mansoury ST; Eissa MM; Shalaby TI; Younis LK; Rashed HA
Acta Trop; 2022 Jan; 225():106215. PubMed ID: 34687647
[TBL] [Abstract][Full Text] [Related]
19. Immunological, histopathological, and ultrastructural evidence of steroid-induced reactivation of chronic murine toxoplasmosis.
Abdel-Magied AA; Ghorab DS; Elhenawy AA; Aboulfotouh NI
Ultrastruct Pathol; 2021 Jan; 45(1):28-36. PubMed ID: 33377812
[TBL] [Abstract][Full Text] [Related]
20. Ginger Is a Potential Therapeutic for Chronic Toxoplasmosis.
El-Kady AM; Al-Megrin WAI; Abdel-Rahman IAM; Sayed E; Alshehri EA; Wakid MH; Baakdah FM; Mohamed K; Elshazly H; Alobaid HM; Qahl SH; Elshabrawy HA; Younis SS
Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
